TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Stories

  1. NFL coaches weigh in on Polamalu’s legacy
  2. Penguins slip past Sharks, 3-2, in shootout
  3. Pirates’ outfield may have few defensive peers
  4. Sex-soaked culture faulted for fraternity house parties
  5. Penguins’ Letang leaves hospital, out with concussion
  6. Hempfield infant fights rare disease
  7. Penguins notebook: Five defensemen dress against San Jose
  8. Starkey: Next frontier for Steelers offense
  9. LaBar: WrestleMania 31 one of the best ever
  10. Pirates notebook: Decker leaves game with calf injury
  11. Researchers uncover details to help get GOP candidates elected